These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34893769)

  • 1. The race to make vaccines for a dangerous respiratory virus.
    Powell K
    Nature; 2021 Dec; 600(7889):379-380. PubMed ID: 34893769
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing respiratory syncytial virus (RSV) disease in children.
    Karron RA
    Science; 2021 May; 372(6543):686-687. PubMed ID: 33986169
    [No Abstract]   [Full Text] [Related]  

  • 3. 2013 Runners-Up. In vaccine design, looks do matter.
    Science; 2013 Dec; 342(6165):1442-3. PubMed ID: 24357293
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
    Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Passive and active immunization against respiratory syncytial virus for the young and old.
    Villafana T; Falloon J; Griffin MP; Zhu Q; Esser MT
    Expert Rev Vaccines; 2017 Jul; 16(7):1-13. PubMed ID: 28525961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
    Hwang HS; Lee YT; Kim KH; Park S; Kwon YM; Lee Y; Ko EJ; Jung YJ; Lee JS; Kim YJ; Lee YN; Kim MC; Cho M; Kang SM
    Virology; 2016 Jul; 494():215-24. PubMed ID: 27123586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection.
    Liang B; Munir S; Amaro-Carambot E; Surman S; Mackow N; Yang L; Buchholz UJ; Collins PL; Schaap-Nutt A
    J Virol; 2014 Apr; 88(8):4237-50. PubMed ID: 24478424
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RSV Vaccines, Finally Within Reach, Could Prevent Tens of Thousands of Yearly Deaths.
    Abbasi J
    JAMA; 2022 Jan; 327(3):204-206. PubMed ID: 34964806
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of Respiratory Syncytial Virus F Glycoprotein Conformation on Induction of Protective Immune Responses.
    Palomo C; Mas V; Thom M; Vázquez M; Cano O; Terrón MC; Luque D; Taylor G; Melero JA
    J Virol; 2016 Jun; 90(11):5485-5498. PubMed ID: 27009962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant varicella vaccine harboring a respiratory syncytial virus gene induces humoral immunity.
    Murakami K; Matsuura M; Ota M; Gomi Y; Yamanishi K; Mori Y
    Vaccine; 2015 Nov; 33(45):6085-92. PubMed ID: 26116253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV.
    Turner TM; Jones LP; Tompkins SM; Tripp RA
    J Virol; 2013 Oct; 87(19):10792-804. PubMed ID: 23903841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in formalin-inactivated respiratory syncytial virus (FI-RSV) enhanced disease with RSV G glycoprotein peptide immunization in BALB/c mice.
    Rey GU; Miao C; Caidi H; Trivedi SU; Harcourt JL; Tripp RA; Anderson LJ; Haynes LM
    PLoS One; 2013; 8(12):e83075. PubMed ID: 24376637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of maternal antibodies on neonatal immunization against respiratory viruses.
    Crowe JE
    Clin Infect Dis; 2001 Nov; 33(10):1720-7. PubMed ID: 11595986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antigens for RSV vaccines.
    Graham BS; Modjarrad K; McLellan JS
    Curr Opin Immunol; 2015 Aug; 35():30-8. PubMed ID: 26070108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of recombinant measles vaccine expressing fusion protein of respiratory syncytial virus in cynomolgus monkeys.
    Sawada A; Yunomae K; Nakayama T
    Microbiol Immunol; 2018 Feb; 62(2):132-136. PubMed ID: 29194753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody.
    McLellan JS; Chen M; Leung S; Graepel KW; Du X; Yang Y; Zhou T; Baxa U; Yasuda E; Beaumont T; Kumar A; Modjarrad K; Zheng Z; Zhao M; Xia N; Kwong PD; Graham BS
    Science; 2013 May; 340(6136):1113-7. PubMed ID: 23618766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological challenges and technological opportunities for respiratory syncytial virus vaccine development.
    Graham BS
    Immunol Rev; 2011 Jan; 239(1):149-66. PubMed ID: 21198670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal transfer of RSV immunity in cotton rats vaccinated during pregnancy.
    Blanco JCG; Pletneva LM; Oue RO; Patel MC; Boukhvalova MS
    Vaccine; 2015 Oct; 33(41):5371-5379. PubMed ID: 26335771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccines against respiratory syncytial virus: The time has finally come.
    Graham BS
    Vaccine; 2016 Jun; 34(30):3535-41. PubMed ID: 27182820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.